Today: 10 June 2026
Marvell stock slides after $540 million XConn deal — here’s what Wall Street is pricing in
7 January 2026
1 min read

Marvell stock slides after $540 million XConn deal — here’s what Wall Street is pricing in

New York, January 7, 2026, 14:09 EST — Regular session

  • Marvell shares fall about 4% in afternoon trading, reversing part of Tuesday’s deal-driven pop
  • Chipmaker agreed to buy XConn for about $540 million to deepen AI data-center switching portfolio
  • Investors focus on timing: revenue contribution flagged for the second half of fiscal 2027

Marvell Technology, Inc. shares fell about 4% on Wednesday, giving back some of the prior session’s gain after the chipmaker unveiled a fresh acquisition aimed at data-center connectivity. The stock was down $3.66 at $84.57 in afternoon trade.

The retreat comes as investors weigh how fast Marvell can turn a push into AI infrastructure into sales growth, and whether it can defend share against larger rivals with deep customer ties. Marvell said on Tuesday it would buy networking equipment provider XConn Technologies in a deal valued at about $540 million; analysts tracked by LSEG see Marvell revenue of $12.75 billion in fiscal 2027.

Marvell said the purchase will be paid in a mix of roughly 60% cash and 40% stock, with the stock portion set off the company’s 20-day volume-weighted average price, or VWAP. The deal is expected to close early in calendar 2026, and Marvell said XConn’s products should begin contributing revenue in the second half of fiscal 2027, becoming accretive to non-GAAP earnings and ramping to about $100 million in fiscal 2028.

XConn makes PCI Express (PCIe) and Compute Express Link (CXL) switching silicon — standards used to link processors, accelerators and memory inside modern servers — and it bolsters Marvell’s Ultra Accelerator Link (UALink) work aimed at “scale-up” connections for large AI systems. RCR Wireless News

“This combination creates a compelling switching platform for accelerated infrastructure,” Marvell Chief Executive Matt Murphy said. XConn CEO Gerry Fan said the company has built the industry’s “highest-port-count” advanced PCIe switching portfolio. Yahoo Finance

Marvell’s drop outpaced the broader chip complex on Wednesday: the iShares Semiconductor ETF was down about 1.3% and the VanEck Semiconductor ETF slipped about 0.6%, while Nvidia and Broadcom were both higher. Marvell touched $83.64 earlier in the session.

Some investors are also looking at the calendar: the revenue lift Marvell is pitching from XConn is back-end loaded, and the market has been unforgiving when deal synergies sit a couple of years out. Switching — the chips and software that route data through a data center — is a battleground where customers fixate on latency, power and reliability, not just top-line bandwidth.

But the bet comes with the usual hazards. Regulatory approvals could stretch the timetable, and execution risk rises when an acquirer has to integrate talent and product roadmaps while competing with entrenched vendors. If standards such as UALink fail to gain traction, or if AI data-center builds cool, the payoff from the deal could be smaller and slower than investors want.

Next up, shareholders face the Jan. 9 record date for Marvell’s $0.06 quarterly dividend, with payment due Jan. 29, a filing showed, while traders watch for any new detail on the XConn closing timeline.

Stock Market Today

  • Palantir Technologies (PLTR) Shares Seen Fairly Valued Amid Recent Decline
    June 10, 2026, 5:48 PM EDT. Palantir Technologies has seen its share price fall 13.2% over the past week and 21.3% year to date, following extraordinary gains in prior years. At $132.07 per share, Palantir trades slightly below its estimated intrinsic value of $145.11 based on a Discounted Cash Flow (DCF) analysis, suggesting a modest 9% discount. The company posted $2.69 billion in free cash flow over the past twelve months, with projections rising to $16.11 billion by 2030. Despite recent volatility tied to sentiment on artificial intelligence and software spending, Palantir remains fairly valued but not a clear bargain. Investors should monitor further market developments and valuation metrics to gauge future opportunities or risks.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings
Previous Story

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

Europa Clipper’s UV look at Comet 3I/ATLAS backs water-ice call as radio “technosignature” scan finds none
Next Story

Europa Clipper’s UV look at Comet 3I/ATLAS backs water-ice call as radio “technosignature” scan finds none

Go toTop